Jacobs & CO Organon & Co. Transaction History

Jacobs & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$30.45 - $39.36 $215,707 - $278,826	-7,084 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$28.67 - $37.13 $70,069 - $90,745	-2,444 Reduced 25.65%	7,084 $215,000
Q3 2021 Oct 13, 2021	SELL	$28.63 - $35.64 $61,039 - $75,984	-2,132 Reduced 18.28%	9,528 $312,000
Q2 2021 Jul 15, 2021	BUY	$28.45 - $38.0 $331,727 - $443,080	11,660 New	11,660 $352,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

Stay updated on Jacobs & CO with notifications on news.